NO20075690L - Avlevering av tigesyklin i naervaer av heparin - Google Patents

Avlevering av tigesyklin i naervaer av heparin

Info

Publication number: NO20075690L
Authority: NO; Norway
Prior art keywords: heparin; tiger; cyclin; delivery; tigecycline
Prior art date: 2005-05-06

Application number

NO20075690A

Other languages

English (en)

Norwegian (no)

Inventor

Pooja Gandhi

Stephen A Ludwig

Maja Vencl-Joncic

Joseph Gross

Julianna Koczone

Original Assignee

Wyeth Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-05-06

Filing date

2007-11-08

Publication date

2008-01-31

2007-11-08 Application filed by Wyeth Corp filed Critical Wyeth Corp

2008-01-31 Publication of NO20075690L publication Critical patent/NO20075690L/no

Links

HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 title abstract 3
229960002897 heparin Drugs 0.000 title abstract 3
229920000669 heparin Polymers 0.000 title abstract 3
102000016736 Cyclin Human genes 0.000 title 1
108050006400 Cyclin Proteins 0.000 title 1
241000282376 Panthera tigris Species 0.000 title 1
FPZLLRFZJZRHSY-HJYUBDRYSA-N tigecycline Chemical compound C([C@H]1C2)C3=C(N(C)C)C=C(NC(=O)CNC(C)(C)C)C(O)=C3C(=O)C1=C(O)[C@@]1(O)[C@@H]2[C@H](N(C)C)C(O)=C(C(N)=O)C1=O FPZLLRFZJZRHSY-HJYUBDRYSA-N 0.000 abstract 2
229960004089 tigecycline Drugs 0.000 abstract 2
238000002648 combination therapy Methods 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Molecular Biology (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Medical Preparation Storing Or Oral Administration Devices (AREA)
Infusion, Injection, And Reservoir Apparatuses (AREA)

NO20075690A 2005-05-06 2007-11-08 Avlevering av tigesyklin i naervaer av heparin NO20075690L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US67820305P	2005-05-06	2005-05-06
PCT/US2006/016860 WO2006121713A2 (en)	2005-05-06	2006-05-02	Delivery of tigecycline in the presence of heparin

Publications (1)

Publication Number	Publication Date
NO20075690L true NO20075690L (no)	2008-01-31

Family

ID=36973003

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20075690A NO20075690L (no)	2005-05-06	2007-11-08	Avlevering av tigesyklin i naervaer av heparin

Country Status (14)

Country	Link
US (1)	US20060251705A1 (pt)
EP (1)	EP1877064A2 (pt)
JP (1)	JP2008540431A (pt)
KR (1)	KR20080005599A (pt)
CN (1)	CN101171016A (pt)
AU (1)	AU2006244588A1 (pt)
BR (1)	BRPI0611070A2 (pt)
CA (1)	CA2607143A1 (pt)
CR (1)	CR9491A (pt)
MX (1)	MX2007013895A (pt)
NO (1)	NO20075690L (pt)
RU (1)	RU2007140956A (pt)
WO (1)	WO2006121713A2 (pt)
ZA (1)	ZA200709510B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR102595895B1 (ko) *	2015-11-27	2023-10-31	삼성전자 주식회사	상황인식 리소스 핫플러그 관리 시스템 및 방법
WO2019139877A1 (en) *	2018-01-10	2019-07-18	The University Of North Carolina At Chapel Hill	Tigecycline for topical treatment of root canal space
WO2020082168A1 (en)	2018-10-23	2020-04-30	Abk Biomedical Incorporated	Delivery device

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5494903A (en) *	1991-10-04	1996-02-27	American Cyanamid Company	7-substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines
JP2004501965A (ja) *	2000-06-30	2004-01-22	ファルマシア・アンド・アップジョン・カンパニー	細菌感染を治療するための組成物および方法
BRPI0620430A2 (pt) *	2005-12-22	2011-11-08	Wyeth Corp	métodos para tratar infecções do trato gastrointestinal com tigeciclina

2006
- 2006-05-02 BR BRPI0611070-3A patent/BRPI0611070A2/pt not_active Application Discontinuation
- 2006-05-02 KR KR1020077028116A patent/KR20080005599A/ko not_active Withdrawn
- 2006-05-02 CA CA002607143A patent/CA2607143A1/en not_active Abandoned
- 2006-05-02 CN CNA2006800155167A patent/CN101171016A/zh active Pending
- 2006-05-02 RU RU2007140956/15A patent/RU2007140956A/ru not_active Application Discontinuation
- 2006-05-02 MX MX2007013895A patent/MX2007013895A/es unknown
- 2006-05-02 EP EP06758939A patent/EP1877064A2/en not_active Withdrawn
- 2006-05-02 WO PCT/US2006/016860 patent/WO2006121713A2/en not_active Ceased
- 2006-05-02 JP JP2008510140A patent/JP2008540431A/ja not_active Withdrawn
- 2006-05-02 AU AU2006244588A patent/AU2006244588A1/en not_active Abandoned
- 2006-05-05 US US11/418,999 patent/US20060251705A1/en not_active Abandoned
2007
- 2007-10-31 CR CR9491A patent/CR9491A/es not_active Application Discontinuation
- 2007-11-05 ZA ZA200709510A patent/ZA200709510B/xx unknown
- 2007-11-08 NO NO20075690A patent/NO20075690L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
JP2008540431A (ja)	2008-11-20
CA2607143A1 (en)	2006-11-16
WO2006121713A2 (en)	2006-11-16
CR9491A (es)	2008-02-21
WO2006121713A3 (en)	2007-03-22
AU2006244588A1 (en)	2006-11-16
CN101171016A (zh)	2008-04-30
RU2007140956A (ru)	2009-06-20
KR20080005599A (ko)	2008-01-14
EP1877064A2 (en)	2008-01-16
MX2007013895A (es)	2008-01-28
BRPI0611070A2 (pt)	2010-08-03
US20060251705A1 (en)	2006-11-09
ZA200709510B (en)	2008-11-26

Similar Documents

Publication	Publication Date	Title
NL301145I2 (nl)	2021-12-07	Tirbanibulin
EA200870185A1 (ru)	2008-12-30	Комбинации ингибиторов ang2 и vegf
TW200744568A (en)	2007-12-16	Epinephrine dosing regimens
PH12017502286A1 (en)	2019-11-11	Monoclonal antibodies against tissue factor pathway by inhibitor (tfpi)
NO20092637L (no)	2009-09-11	Fremgangsmater for behandling
PH12014500053A1 (en)	2015-03-30	Proteasome inhibitors
MY160041A (en)	2017-02-15	Compositions and methods for treating parasitic infections
UA118248C2 (uk)	2018-12-26	Інгібітори глюкозилцерамідсинтази
CL2010001426A1 (es)	2011-07-15	Compuestos derivados de triciclos, inhibidores de la proteina quinasa; composicion farmaceutica que los comprende; utiles en el tratamiento de enfermedades oncologicas e inmunologicas.
EA201101521A1 (ru)	2012-09-28	Способы лечения онкологических заболеваний, использующие эпиметаболические переключатели, многоаспектные внутриклеточные молекулы или факторы влияния
TW200716646A (en)	2007-05-01	(S)-N-methylnaltrexone
MX2015002371A (es)	2015-10-05	Inhibidores bivalentes de las proteinas iap y metodos terapueticos que usan los mismos.
PH12018500641A1 (en)	2019-07-29	Optimized monoclonal antibodies against tissue factor pathway inhibitor (tfpi)
EA201390803A1 (ru)	2013-09-30	Ингибиторы бромодомена и их применение
AR048819A1 (es)	2006-05-31	Metodos sinergicos y composiciones para el tratamiento del cancer
MX2018013333A (es)	2020-11-12	Composiciones de nucleasas terapeuticas y metodos.
SG161318A1 (en)	2010-05-27	Heterocyclic inhibitors of mek and methods of use thereof
NO20082120L (no)	2008-06-18	Behandling og forebyggelse av mikroangiopati
EA201101117A1 (ru)	2012-03-30	Ингибиторы дпп-4 для лечения диабета у детей
ATE489371T1 (de)	2010-12-15	Benzamidglucokinaseaktivatoren
MX2010006206A (es)	2011-03-04	Derivados de oxindol substituidos por 5-halogeno y el uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina.
MY149606A (en)	2013-09-13	Therapeutic compositions comprising hyaluronan and therapeutic antibodies as well as methods of treatment
IN2014DN08385A (pt)	2015-05-08
NO20074780L (no)	2007-11-01	Heterocyklylamidsubstituerte imidazoler
MA32321B1 (fr)	2011-05-02	Pregn-4-en-21, 17 carbolactones substitués sur le noyau c, et préparations pharmaceutiques contenant ces derniers

Legal Events

Date	Code	Title	Description
2009-12-21	FC2A	Withdrawal, rejection or dismissal of laid open patent application